Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Only 8% of pharmacy teams point to Nexium Control as heartburn treatment, GSK survey finds

Just 8% of pharmacy team members would recommend proton pump inhibitors (PPIs) – such as Nexium Control – as a first-line treatment for frequent heartburn, a GlaxoSmithKline (GSK) survey has revealed. 

Instead, pharmacists prefer offering antacids or alginate, according to the survey results.

The GSK-commissioned survey – which was conducted in September last year and collated responses from 250 pharmacy team members – was launched to better understand how pharmacists help their patients to treat frequent heartburn.

It also revealed that pharmacy teams describe “frequent” heartburn as something occurring four to six times a week. However, GSK pointed at literature suggesting that heartburn occurring more than once a week is considered “frequent”.

Lisa Phillips, expert marketing manager for Nexium Control at GSK Consumer Healthcare, said: “Our Nexium Control brand leads the PPI subcategory and offers long-lasting and effective treatment.

“We’re committed to ensuring pharmacy teams remain upskilled and understand the role that PPIs can play in managing frequent heartburn.”

For further information on the Nexium Control range, visit the GSK website

Topics


         
Pharmacist
Stamford, Lincolnshire
£50-55,000 per annum

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD135813

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel